Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
timolol maleate, Quantity: 6.8 mg/mL (Equivalent: timolol, Qty 5 mg/mL); bimatoprost, Quantity: 0.3 mg/mL
Abbvie Pty Ltd
Bimatoprost,Timolol maleate
Eye Drops, solution
Excipient Ingredients: dibasic sodium phosphate heptahydrate; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; hydrochloric acid; sodium chloride
Ophthalmic
1 x 3mL bottle in carton
(S4) Prescription Only Medicine
GANFORT eye drops are indicated for the reduction of intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.
Visual Identification: Clear and colourless to slightly yellow solution; Container Type: Bottle; Container Material: LDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2009-05-15
GANFORT ® 0.3/5 bimatoprost 0.3 mg per mL & timolol (as maleate) 5.0 mg per mL Eye Drops CMIv6 1 GANFORT ® 0.3/5 EYE DROPS (BIMATOPROST 0.3 MG PER ML AND TIMOLOL (AS MALEATE) 5.0 MG PER ML) CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about GANFORT ® 0.3/5 eye drops. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using GANFORT ® 0.3/5 eye drops against the benefits they expect it will have for you. If you have any concerns about using this medicine, ask your doctor or pharmacist. KEEP THIS LEAFLET WITH THE MEDICINE. YOU MAY NEED TO READ IT AGAIN. WHAT GANFORT ® 0.3/5 EYE DROPS ARE USED FOR GANFORT ® 0.3/5 eye drops are used to lower raised pressure in the eye and to treat glaucoma. Glaucoma is a condition in which the pressure of fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure. Glaucoma is usually caused by a build up of the fluid which flows through the eye. This build up occurs because the fluid drains out of your eye more slowly than it is being pumped in. Since new fluid continues to enter the eye, joining the fluid already there, the pressure continues to rise. This raised pressure may damage the back of the eye resulting in gradual loss of sight. Damage can progress so slowly that the person is not aware of this gradual loss of sight. Sometimes even normal eye pressure is associated with damage to the back of the eye. There are usually no symptoms of glaucoma. The only way of knowing that you have glaucoma is to have your eye pressure, optic nerve and visual field checked by an eye specialist or optometrist. If glaucoma is not treated it can lead to serious problems, including total blindness. In fact, untreated glaucoma is one of the most common causes of blindness. GANFORT ® 0.3/5 eye drops lower the pressure in the eye by decreasing the fluid produced Read the complete document
GANFORT ® PI v6 CCDS v4 1 AUSTRALIAN PRODUCT INFORMATION GANFORT ® 0.3/5 (BIMATOPROST AND TIMOLOL (AS MALEATE)) EYE DROPS 1 NAME OF THE MEDICINE Bimatoprost and Timolol (as maleate) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Bimatoprost 0.3 mg/mL and Timolol (as maleate) 5.0 mg/mL Excipient with known effect: benzalkonium chloride (used as preservative). For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Eye drops, solution. Clear and colourless to slightly yellow solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS GANFORT ® 0.3/5 eye drops are indicated for the reduction of intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy. 4.2 DOSE AND METHOD OF ADMINISTRATION The recommended dose is one drop of GANFORT ® 0.3/5 in the affected eye(s) once daily, administered in the morning. In order to minimise systemic absorption of GANFORT ® 0.3/5 eye drops, apply pressure to the tear duct immediately following administration of the drug (See _ Section 4.4 Special _ _warnings and precautions for use_ ). As with all eye drops containing benzalkonium chloride as a preservative, there is potential for incompatibility with other topical ophthalmic medications. If more than one topical ophthalmic medicinal product is to be used, other eye drops should not be used within five to ten minutes of using GANFORT ® 0.3/5 eye drops. INFORMATION FOR PATIENTS - USE WITH CONTACT LENSES The preservative in GANFORT ® 0.3/5 eye drops, benzalkonium chloride, may be absorbed by and cause discolouration of soft contact lenses. Patients wearing soft (hydrophilic) contact lenses should be instructed to remove them prior to administration and wait at least 15 minutes after instilling GANFORT ® 0.3/5 eye drops before reinserting soft contact lenses. GANFORT ® PI v6 CCDS v4 2 Avoid allowing the tip of the dispensing container to contact the eye or surrounding structures to avoid eye injury and contamina Read the complete document